子午流注纳子针法对支气管哮喘的防治研究
摘要
支气管哮喘是严重影响人们健康的常见病、多发病。据粗略估计,我国约有1500-2000万哮喘患者。哮喘给社会带来沉重负担,造成误工、误学,对患者的生活质量有很大影响。随着城市化发展,现代文明生活的进步,哮喘患病率逐年上升,已成为仅次于癌症的世界第二大致死和致残疾病。因此,哮喘已成为严重的公共卫生问题,受到各国的极大关注,哮喘的防治研究随之形成一个独立的医学体系。
研究目的:
通过回顾历代文献,总结近年来中医药对本病的研究进展及延续导师以前的研究领域,探讨子午流注纳子针法对支气管哮喘的治疗作用,从细胞因子角度证实其治疗支气管哮喘的机理,丰富以防为主治疗治疗哮喘的措施,解决推算按时开穴的繁杂性及临床治疗时间的局限性,开启子午流注按时选穴的思维,为子午流注纳子针法临床的推广应用提供客观的依据。
研究方法:
临床确诊为支气管哮喘患者。纳入标准:①诊断符合支气管哮喘的标准;②治疗前哮喘病情严重程度分级为第1,2,3级。排除标准:①治疗前哮喘病情严重程度分级为第4级;②合并有肝、肾、造血系统和内分泌系统等严重原发性疾病,或伴有精神疾病患者;③凡符合纳入标准,未按规定治疗,无法判断疗效或资料不全等影响疗效判断者。按入院顺序依照随机数字表随机分为子午流注纳子针法组(观察组)和常规针法组(对照组)各30例。子午流注纳子针法组取穴:太溪_双、阴谷_双、肾俞_双,刺激方法:固定在每天的酉时治疗,快速捻转进针,平补平泻,实证适当取定喘,虚证加太渊。留针30min,每10min行针1次,约1min。常规针法组取穴:膻中、列缺_双、肺俞_双,刺激方法:在每天酉时以外的时间治疗,其余同子午流注纳子针法组。治疗每日1次,10次为1疗程,休息5天,继续下一疗程,共治疗4疗程后复查指标。观察针刺前后各项指标的水平,进行临床疗效及实验数据比较。
结果:
1子午流注纳子针法对哮喘控制的影响。
参照南非Bateman在“GOAL”全球多中心临床试验中设定的哮喘完全控制和良好控制两种概念,治疗不能达到良好控制标准的定义为没有控制,从哮喘临床症状、肺通气功能、治疗强度等方面观察临床疗效,经过4个疗程治疗后,数据显示两种针法均可改善患者哮喘症状,子午流注纳子针法组总有效率为93.3%,常规针法组总有效率为73.3%。组间比较有显著性差异(p＜0.05),说明子午流注纳子针法较常规针法更有效。
2子午流注纳子针法对哮喘中医临床疗效的影响。
通过两组中医临床疗效比较,我们发现两种针法均可促进患者症状改善,观察组总有效率为93.3%,对照组总有效率为76.6%,组间比较有显著性差异(p＜0.05),说明子午流注纳子针法较常规针法更有效。
3子午流注纳子针法对哮喘症状积分的影响。
通过观察哮喘患者白天和夜间症状积分,显示两种针法均可降低患者症状积分,治疗前后有显著性差异(p＜0.05),组间比较观察组与对照组之间有显著性差异(p＜0.05),说明子午流注纳子针法较常规针法更有效。
4子午流注纳子针法对哮喘患者肺通气功能的影响。
通过测量哮喘患者呼气峰流量(PEF),显示两种针法均可提高患者呼气峰流量(PEF),治疗前后有显著性差异(p＜0.05),组间比较观察组与对照组之间有显著性差异(p＜0.05),说明子午流注纳子针法较常规针法更有效。
5子午流注纳子针法对哮喘患者治疗强度的影响。
通过计算哮喘患者急用短效β2受体激动剂次数,显示两种针法均可减少患者使用次数,治疗前后有显著性差异(p＜0.05),组间比较观察组与对照组之间有显著性差异(p＜0.05),说明子午流注纳子针法较常规针法更有效。
6子午流注纳子针法对哮喘患者血清中IL-4的影响
经过4个疗程治疗后,IL-4水平较治疗前有显著性降低,治疗前后有显著性差异(p＜0.05),提示两组患者治疗后均有效。组间比较观察组与对照组之间有显著性差异(p＜0.01),显示子午流注纳子针法较常规针法更有效。
结论:
(一)子午流注纳子针法能改善哮喘控制。
(二)子午流注纳子针法能提高中医临床疗效。
(三)子午流注纳子针法能降低哮喘症状积分。
(四)子午流注纳子针法能提高哮喘患者呼气峰流量(PEF)。
(五)子午流注纳子针法能降低哮喘患者治疗强度。
(六)子午流注纳子针法能降低哮喘患者血清IL-4水平。
以上研究结果表明,无论是哮喘临床症状,还是IL-4水平的改善方面,两组针法治疗前后均有显著的差异性,而子午流注纳子针法效果明显优于常规针法。说明子午流注纳子针法能更好的控制哮喘症状、改善肺通气功能、降低治疗强度,同时通过对IL-4的影响,从免疫学机制、气道上皮损伤与气道重构、气道神经源性炎症等方面来调控哮喘的发生发展机制,达到了治疗哮喘的目的。
Bronchial asthma is a common diease which serious impacts on people's health.According to a rough estimate,In our country there are about 15-20 million people with asthma.Asthma is a heavy burden to our society,resulting in loss of working time,moreover it has a significant impact on the quality of life of patients.With the development of modern civilization,asthma increased year by year,only after the cancer and become the world's second largest death and disabling disease.Therefore,asthma has become a serious public health problem which is great concerned by many States.
objective:
By reviewing past literature,summed up chinese medicine research on the disease in recent years and continuated my mentors previous research to explore the study of nazi method of Ziwu Liuzhu acutheropy on the treatment of bronchial asthma,confirmed the mechanism of the treatment of bronchial asthma from the perspective of cytokines,riched treatments,resolving the complication of selection acupoints on time and the time limitations of clinical treatment,open a new hope for how to use nazi method of Ziwu Liuzhu acutheropy to select acupuncture pionts on time,providing objective basis to satisfied the promotion of clinical applications of nazi method of Ziwu Liuzhu acutheropy.
method:
Clinical patients diagnosed with bronchial asthma.Inclusion criteria:①diagnostic criteria for bronchial asthma;②pre-treatment severity of asthma for the 1,2,3-grade.exclusion criteria:①pre-treatment severity of asthma for the 4 grade;②combined serious primary disease of liver、kidney、hematopoietic system and endocrine system,the mentally illness;③meet the requirements of the standard,can not receive regular treatment,can not determine the effectiveness of treatment or insufficient information to determine those effects and so on.All the patients were randomly divided into nazi method of Ziwu Liuzhu acutheropy group(observation group) and routine acupuncture group(control group) and each group have 30 cases. Acupoints of observation group:TaiXi,Yin Gu,ShenShu.stimulate methods: fixed in you shi treatment every day,rapid contortus needle,using Dingchuan with empirical patients and TaiYuan with deficiency patients.Left the needles 30min,stimulate needles about 1min every 10mins.Acupoints of contral group:lieQue,ShanZhong,FeiShu.stimulate Methods:treatment fixed off you shi every day,rapid contortus needle,using Dingchuan with empirical patients and TaiYuan with deficiency patients.Left the needles 30min,stimulate needles about 1min every 10mins.All patients receive one treatment per day, 10 times for one course of treatment,five days to rest and continue the next course of treatment,Observed the indicators after a total of 4 treatments, Comparised the clinical efficacy and experimental data.
result:
1 the impact of nazi method of Ziwu Liuzhu acutheropy on the asthma control in the light of Bateman of South Africa who sets the two concepts of asthma total control and good control of in "GOAL" global,multi-center clinical trials of asthma.treatment result can not achieve good control we define as no control,observing the clinical symptoms of asthma,the treatment of strength,pulmonary ventilation function,after 4 treatment courses,statistics show that two type of acupuncture methods can improve symptoms in patients with asthma,the result before and after treatment is significantly different (p＜0.05),the total effective rate of observation group is 93.3%,control group is 73.3%,comparison between observation group and control group is significant difference(p＜0.05),this is satisfied that nazi method of Ziwu Liuzhu acutheropy is more effective than conventional acupuncture.
2 the impact of nazi method of Ziwu Liuzhu acutheropy on the asthma clinical curative effect of Chinese medicine
Through the clinical effects of the two groups,we found that the two typesof acupuncture methods can improve symptoms in patients with asthma,the result before and after treatment is significant different(p＜0.05),the total effective rate of observation group is 93.3%,while the control group is 76.6%, comparison between the two groups is significant difference(p＜0.05),this is satisfied that nazi method of Ziwu Liuzhu acutheropy is more effective than conventional acupuncture.
3 the impact of nazi method of Ziwu Liuzhu acutheropy on the asthma symptoms score.
Through observing symptom score of patients with asthma during the day and night,the data shows that the two Acupuncture methods can reduce the score in patients with asthma,the result before and after treatment is significantly different(p＜0.05),comparison between observation group and control group is significant difference(p＜0.05),this is satisfied that nazi method of Ziwu Liuzhu acutheropy is more effective than conventional acupuncture.
4 the impact of the nazi methodof acutheropy Ziwu Liuzhu on the asthma Pulmonary function
by measuring the peak expiratory flow(PEF),we find that the two type of acupuncture methods can increase the peak expiratory flow(PEF),the result before and after treatment is significantly different(p＜0.05),comparison between observation group and control group is significant difference(p＜0.05),this is satisfied that nazi method of Ziwu Liuzhu acutheropy is more effective than conventional acupuncture.
5 the impact of nazi method of Ziwu Liuzhu acutheropy on the asthma Treatment intensity
By calculating the number of using short-actingβ2 receptor agonist,data shows that the two group of acupuncture methods can reduce the numberber,the result before and after treatment is different(p＜0.05),comparison between observation group and control group is significant difference(p＜0.05),this is satisfied that nazi method of Ziwu Liuzhu acutheropy is more effective than conventional acupuncture.
6 the impact of nazi method of Ziwu Liuzhu acutheropy on serum levels of IL-4
After four course treatments,serum levels of IL-4 before treatment is significantly lower than the level after treatment(p＜0.05),this shows the results of two groups are effective,comparison between observation group and control group is significant difference(p＜0.01),this is satisfied that nazi method of Ziwu Liuzhu acutheropy is more effective than the conventional acupuncture.
conclusion:
1.nazi method of Ziwu Liuzhu acutheropy can improves asthma control.
2.nazi method of Ziwu Liuzhu acutheropy can improves the clinical efficacy of Chinese medicine.
3.nazi method of Ziwu Liuzhu acutheropy can improves asthma symptoms score.
4.nazi method of Ziwu Liuzhu acutheropy can improves the peak expiratory flow of asthma Patients(PEF).
5.nazi method of Ziwu Liuzhu acutheropy can Reduces the intensity of asthma treatment.
6.nazi method of Ziwu Liuzhu acutheropy can Lowers serum levels of IL-4 in patients with asthma.
The above results show that,regardless of asthma Clinical sympyoms or serum levels of IL-4 improvement,before and after acupuncture treatment the results are significant different,whereas nazi method of Ziwu Liuzhu acutberopy is better than conventional acupuncture,nazi method of Ziwu Liuzhu acutheropy can better control asthma symptoms,improve pulmonary function,reduce the treatment intensity,and at the same time through the effects of IL-4,from the immunological mechanisms,airway epithelial injury,airway remodeling and gas road of neurogenic inflammation to control the development mechanisms of asthma and achieve the treating purpose of asthma.
研究目的:
通过回顾历代文献,总结近年来中医药对本病的研究进展及延续导师以前的研究领域,探讨子午流注纳子针法对支气管哮喘的治疗作用,从细胞因子角度证实其治疗支气管哮喘的机理,丰富以防为主治疗治疗哮喘的措施,解决推算按时开穴的繁杂性及临床治疗时间的局限性,开启子午流注按时选穴的思维,为子午流注纳子针法临床的推广应用提供客观的依据。
研究方法:
临床确诊为支气管哮喘患者。纳入标准:①诊断符合支气管哮喘的标准;②治疗前哮喘病情严重程度分级为第1,2,3级。排除标准:①治疗前哮喘病情严重程度分级为第4级;②合并有肝、肾、造血系统和内分泌系统等严重原发性疾病,或伴有精神疾病患者;③凡符合纳入标准,未按规定治疗,无法判断疗效或资料不全等影响疗效判断者。按入院顺序依照随机数字表随机分为子午流注纳子针法组(观察组)和常规针法组(对照组)各30例。子午流注纳子针法组取穴:太溪_双、阴谷_双、肾俞_双,刺激方法:固定在每天的酉时治疗,快速捻转进针,平补平泻,实证适当取定喘,虚证加太渊。留针30min,每10min行针1次,约1min。常规针法组取穴:膻中、列缺_双、肺俞_双,刺激方法:在每天酉时以外的时间治疗,其余同子午流注纳子针法组。治疗每日1次,10次为1疗程,休息5天,继续下一疗程,共治疗4疗程后复查指标。观察针刺前后各项指标的水平,进行临床疗效及实验数据比较。
结果:
1子午流注纳子针法对哮喘控制的影响。
参照南非Bateman在“GOAL”全球多中心临床试验中设定的哮喘完全控制和良好控制两种概念,治疗不能达到良好控制标准的定义为没有控制,从哮喘临床症状、肺通气功能、治疗强度等方面观察临床疗效,经过4个疗程治疗后,数据显示两种针法均可改善患者哮喘症状,子午流注纳子针法组总有效率为93.3%,常规针法组总有效率为73.3%。组间比较有显著性差异(p＜0.05),说明子午流注纳子针法较常规针法更有效。
2子午流注纳子针法对哮喘中医临床疗效的影响。
通过两组中医临床疗效比较,我们发现两种针法均可促进患者症状改善,观察组总有效率为93.3%,对照组总有效率为76.6%,组间比较有显著性差异(p＜0.05),说明子午流注纳子针法较常规针法更有效。
3子午流注纳子针法对哮喘症状积分的影响。
通过观察哮喘患者白天和夜间症状积分,显示两种针法均可降低患者症状积分,治疗前后有显著性差异(p＜0.05),组间比较观察组与对照组之间有显著性差异(p＜0.05),说明子午流注纳子针法较常规针法更有效。
4子午流注纳子针法对哮喘患者肺通气功能的影响。
通过测量哮喘患者呼气峰流量(PEF),显示两种针法均可提高患者呼气峰流量(PEF),治疗前后有显著性差异(p＜0.05),组间比较观察组与对照组之间有显著性差异(p＜0.05),说明子午流注纳子针法较常规针法更有效。
5子午流注纳子针法对哮喘患者治疗强度的影响。
通过计算哮喘患者急用短效β2受体激动剂次数,显示两种针法均可减少患者使用次数,治疗前后有显著性差异(p＜0.05),组间比较观察组与对照组之间有显著性差异(p＜0.05),说明子午流注纳子针法较常规针法更有效。
6子午流注纳子针法对哮喘患者血清中IL-4的影响
经过4个疗程治疗后,IL-4水平较治疗前有显著性降低,治疗前后有显著性差异(p＜0.05),提示两组患者治疗后均有效。组间比较观察组与对照组之间有显著性差异(p＜0.01),显示子午流注纳子针法较常规针法更有效。
结论:
(一)子午流注纳子针法能改善哮喘控制。
(二)子午流注纳子针法能提高中医临床疗效。
(三)子午流注纳子针法能降低哮喘症状积分。
(四)子午流注纳子针法能提高哮喘患者呼气峰流量(PEF)。
(五)子午流注纳子针法能降低哮喘患者治疗强度。
(六)子午流注纳子针法能降低哮喘患者血清IL-4水平。
以上研究结果表明,无论是哮喘临床症状,还是IL-4水平的改善方面,两组针法治疗前后均有显著的差异性,而子午流注纳子针法效果明显优于常规针法。说明子午流注纳子针法能更好的控制哮喘症状、改善肺通气功能、降低治疗强度,同时通过对IL-4的影响,从免疫学机制、气道上皮损伤与气道重构、气道神经源性炎症等方面来调控哮喘的发生发展机制,达到了治疗哮喘的目的。
Bronchial asthma is a common diease which serious impacts on people's health.According to a rough estimate,In our country there are about 15-20 million people with asthma.Asthma is a heavy burden to our society,resulting in loss of working time,moreover it has a significant impact on the quality of life of patients.With the development of modern civilization,asthma increased year by year,only after the cancer and become the world's second largest death and disabling disease.Therefore,asthma has become a serious public health problem which is great concerned by many States.
objective:
By reviewing past literature,summed up chinese medicine research on the disease in recent years and continuated my mentors previous research to explore the study of nazi method of Ziwu Liuzhu acutheropy on the treatment of bronchial asthma,confirmed the mechanism of the treatment of bronchial asthma from the perspective of cytokines,riched treatments,resolving the complication of selection acupoints on time and the time limitations of clinical treatment,open a new hope for how to use nazi method of Ziwu Liuzhu acutheropy to select acupuncture pionts on time,providing objective basis to satisfied the promotion of clinical applications of nazi method of Ziwu Liuzhu acutheropy.
method:
Clinical patients diagnosed with bronchial asthma.Inclusion criteria:①diagnostic criteria for bronchial asthma;②pre-treatment severity of asthma for the 1,2,3-grade.exclusion criteria:①pre-treatment severity of asthma for the 4 grade;②combined serious primary disease of liver、kidney、hematopoietic system and endocrine system,the mentally illness;③meet the requirements of the standard,can not receive regular treatment,can not determine the effectiveness of treatment or insufficient information to determine those effects and so on.All the patients were randomly divided into nazi method of Ziwu Liuzhu acutheropy group(observation group) and routine acupuncture group(control group) and each group have 30 cases. Acupoints of observation group:TaiXi,Yin Gu,ShenShu.stimulate methods: fixed in you shi treatment every day,rapid contortus needle,using Dingchuan with empirical patients and TaiYuan with deficiency patients.Left the needles 30min,stimulate needles about 1min every 10mins.Acupoints of contral group:lieQue,ShanZhong,FeiShu.stimulate Methods:treatment fixed off you shi every day,rapid contortus needle,using Dingchuan with empirical patients and TaiYuan with deficiency patients.Left the needles 30min,stimulate needles about 1min every 10mins.All patients receive one treatment per day, 10 times for one course of treatment,five days to rest and continue the next course of treatment,Observed the indicators after a total of 4 treatments, Comparised the clinical efficacy and experimental data.
result:
1 the impact of nazi method of Ziwu Liuzhu acutheropy on the asthma control in the light of Bateman of South Africa who sets the two concepts of asthma total control and good control of in "GOAL" global,multi-center clinical trials of asthma.treatment result can not achieve good control we define as no control,observing the clinical symptoms of asthma,the treatment of strength,pulmonary ventilation function,after 4 treatment courses,statistics show that two type of acupuncture methods can improve symptoms in patients with asthma,the result before and after treatment is significantly different (p＜0.05),the total effective rate of observation group is 93.3%,control group is 73.3%,comparison between observation group and control group is significant difference(p＜0.05),this is satisfied that nazi method of Ziwu Liuzhu acutheropy is more effective than conventional acupuncture.
2 the impact of nazi method of Ziwu Liuzhu acutheropy on the asthma clinical curative effect of Chinese medicine
Through the clinical effects of the two groups,we found that the two typesof acupuncture methods can improve symptoms in patients with asthma,the result before and after treatment is significant different(p＜0.05),the total effective rate of observation group is 93.3%,while the control group is 76.6%, comparison between the two groups is significant difference(p＜0.05),this is satisfied that nazi method of Ziwu Liuzhu acutheropy is more effective than conventional acupuncture.
3 the impact of nazi method of Ziwu Liuzhu acutheropy on the asthma symptoms score.
Through observing symptom score of patients with asthma during the day and night,the data shows that the two Acupuncture methods can reduce the score in patients with asthma,the result before and after treatment is significantly different(p＜0.05),comparison between observation group and control group is significant difference(p＜0.05),this is satisfied that nazi method of Ziwu Liuzhu acutheropy is more effective than conventional acupuncture.
4 the impact of the nazi methodof acutheropy Ziwu Liuzhu on the asthma Pulmonary function
by measuring the peak expiratory flow(PEF),we find that the two type of acupuncture methods can increase the peak expiratory flow(PEF),the result before and after treatment is significantly different(p＜0.05),comparison between observation group and control group is significant difference(p＜0.05),this is satisfied that nazi method of Ziwu Liuzhu acutheropy is more effective than conventional acupuncture.
5 the impact of nazi method of Ziwu Liuzhu acutheropy on the asthma Treatment intensity
By calculating the number of using short-actingβ2 receptor agonist,data shows that the two group of acupuncture methods can reduce the numberber,the result before and after treatment is different(p＜0.05),comparison between observation group and control group is significant difference(p＜0.05),this is satisfied that nazi method of Ziwu Liuzhu acutheropy is more effective than conventional acupuncture.
6 the impact of nazi method of Ziwu Liuzhu acutheropy on serum levels of IL-4
After four course treatments,serum levels of IL-4 before treatment is significantly lower than the level after treatment(p＜0.05),this shows the results of two groups are effective,comparison between observation group and control group is significant difference(p＜0.01),this is satisfied that nazi method of Ziwu Liuzhu acutheropy is more effective than the conventional acupuncture.
conclusion:
1.nazi method of Ziwu Liuzhu acutheropy can improves asthma control.
2.nazi method of Ziwu Liuzhu acutheropy can improves the clinical efficacy of Chinese medicine.
3.nazi method of Ziwu Liuzhu acutheropy can improves asthma symptoms score.
4.nazi method of Ziwu Liuzhu acutheropy can improves the peak expiratory flow of asthma Patients(PEF).
5.nazi method of Ziwu Liuzhu acutheropy can Reduces the intensity of asthma treatment.
6.nazi method of Ziwu Liuzhu acutheropy can Lowers serum levels of IL-4 in patients with asthma.
The above results show that,regardless of asthma Clinical sympyoms or serum levels of IL-4 improvement,before and after acupuncture treatment the results are significant different,whereas nazi method of Ziwu Liuzhu acutberopy is better than conventional acupuncture,nazi method of Ziwu Liuzhu acutheropy can better control asthma symptoms,improve pulmonary function,reduce the treatment intensity,and at the same time through the effects of IL-4,from the immunological mechanisms,airway epithelial injury,airway remodeling and gas road of neurogenic inflammation to control the development mechanisms of asthma and achieve the treating purpose of asthma.
引文
[1]钟南山.支气管哮喘[M],北京:人民卫生出版社,2006,1-3.
[2]杨贵贞.医学免疫学[M],北京:高等教育出版社,2003,72-75.
[3]O' shea JJ,Gadina M,Schreiber RD.Cytokines signaling in 2002:new surprise in the JAK/STAT pathway.Cell,2002;109(suppl):S121.
[4]Holgate ST.airway inflammation and remodeling in asthma:current concepts.Mol Biotechnol,2002;22(2):179.
[5]Davies DE,Wicks J,Powell RM,et al.airway remodeling in asthma:new insights.J Allergy Clin Immunol,2003:111(20):215.
[6]Payne DN.Nitric oxide in allergic airway inflammation.Curr Opin Allergy Clin Immunol,2003;3(2):133-137.
[7]nogate SP,Koskinen A,Matthae KI,et al.interleukin-5 producing CD4+Tcells play a pivotal role in aeroallergen-induced eosinophilia brochial hypperreactivity and lung damage in mice.AM J Respir Crit Care,1998;157(1):210-218.
[8]Nelms K,Keegan J,Zamorano J,et al.The IL-4 receptor:signaling mechanisms and biologic functions.Annu Rev Immunol,1999;17:701-747.
[9]胡志光.针刺对支气管哮喘患者T细胞亚群和IL-4的影响[J].中国针灸,1999;(2):111.
[10]杜传海,杨军平,邱丽瑛.针刺治疗对哮喘患者血清IL-12、IL-4与IgE水平的影响[J].山东中医杂志,2005;24(7):417-418.
[11]赖新生,李月梅,张家维.天灸对哮喘患者血清可溶性IL-2受体及T淋巴细胞亚群的影响[J].中国针灸,2000;(1):33-34.
[12]白晓红,邵功利,王雪峰.伏九贴膏防治小儿哮喘的临床研究探要[J].中医药学刊,2004;22(9):1637.
[13]付明举,黄红梅,吴华青,穴位埋线治疗支气管哮喘的临床研究[J].河北医学,2005;11(6):505-506.
[14]周丽莎,朱书秀,涂 乾.潜伏期天灸对哮喘模型大鼠的影响[J].陕西中医,2005;26(5):471-472.
[15]刘冠军,顾光.子午流注与针灸推转盘[M],上海:上海科学技术出版社,1983:5-7.
[16]承淡安,陈璧琉,徐惜年.子午流注针法[M],南京:江苏人民出版社,1958:1 -3.
[17]吴槕仙.子午流注说难[M],成都:四川人民出版社,1958:10-13.
[18]胡国俊.哮喘治痰一得[J].中医杂志,1997;38(12):723.
[19]宋涌文.温肾健脾祛痰法控制支气管哮喘复发30例[J].浙江中医杂志,1998;33(1):2822.
[20]陈玉龙,邱晓荣,尹超英,等.从瘀血谈支气管哮喘证治[J].河南中医药学刊,1998:13(1):19.
[21]方永奇.痰证的血液循环特征初探[J].湖北中医杂志,1993;14(6):33.
[22]许德金.丹参防治支气管哮喘的临床及血液流变学的研究观察[J].江苏中医,1992:13(9):38.
[23]曲文华,清热化痰佐以补肾温阳治疗热哮36例[J],山东中医杂志,1996;15(2):62.
[24]许得盛,沈自尹,王文健,等.补肾健脾法在防治重症哮喘中的作用探讨[J].中国中西医结合杂志,1997;17(10):584.
[25]沈自尹.中西医结台防治支气管哮喘的探讨[J].中国中西医结合杂志,1995;15(7):426.
[26]董桂青.苓甘五昧姜辛汤合二陈汤加减治疗咳嗽变异性哮60例[J].国医论坛,2008;23(5):24-25.
[27]张宾.平气散加减治疗哮喘54例[J].实用中医内科杂志,2008;22(9):19-20.
[28]杨静,陈雅民.宣肺化瘀汤治疗小儿哮喘50例[J].中国中医急症,2008;17(9):1291.
[29]张文彭.针刺对支气管哮喘患者临床症状与肺功能的影响[J].中国针灸,2006;26(11):763-767.
[30]孙爱娟.针刺治疗哮喘的临床观察[J].Chinese Journal of the Practical Chinese with Modern Medicine,2007;201(7):588.
[31]刘富生.针灸三联法治疗哮喘30例[J].实用中医药杂志,2006;22(1):24-25.
[32]王又平,高丽华.针灸治疗哮喘50例临床观察[J].光明中医,2008;23(1):23-24.
[33]胡伟勇.子年流注针法治疗支气管哮喘65例临床观察[J].江西中医学院学报,1995;7(4):11.
[34]刘宏.化脓灸治疗外感性支气管哮喘发作期疗效观察[J].辽宁中医杂志,2005;32(1):55.
[35]陆亚康.“三伏灸”防治支气管哮喘117例临床观察[J].针灸临床杂志,1999; 15(1):29-31.
[36]刘明清,黄启嵩.化脓灸治疗支气管哮喘的临床疗效观察[J].中国针灸,2002;22(8):537-539.
[37]米建平,刘炳权.天灸疗法防治支气管哮喘18l例疗效观察[J].新中医,2005;37(2):61-62.
[38]李磊,高尚轸,王忠英.背俞穴埋线疗法治疗支气管哮喘临床观察[J].针灸临床杂志,2005;21(6):41.
[39]张琳,赵晓晨,靳聪妮.埋线疗法治疗支气管哮喘246例临床观察[J].山西中医学院院报,2007;8(4):32-33.
[40]张鲜萍.穴位埋线法治疗支气管哮喘36例临床观察[J].山西中医,2006;22(6):33.
[41]周小鸿,陈立生.穴位十字形埋线治疗支气管哮喘56例疗效观察[J].新中医,2007;39(8):65-66.
[42]韩慧敏.冬病夏治穴位敷贴法治疗老年哮喘缓解期[J].Chinese Journal of RehabIlitation,2008;23(4):240.
[43]赵卫国,吕素君.穴位敷贴治疗支气管哮喘56例[J].中国中医急症,2008;17(1):74.
[44]袁保丰,秦黎虹,张建华.穴位贴敷次数对缓解期哮喘患者肺功能的影响[J].云南中医中药杂志,2007;28(9):9.
[45]张舒雁,马泽云.穴位贴敷法防治哮喘88例[J].中华中医药学刊,2007;25(3):547.
[46]毕关芬.药物穴位贴敷治疗小儿支气管哮喘160例[J].实用中西医结合临床,2005;5(5):54-55.
[47]高洪英,徐建勇.痰热清穴位注射治疗支气管哮喘52例[J].时珍国医国药,2006;17(9):1754-1755.
[48]项春福.穴位注射治疗支气管哮喘42例[J].现代中西医结合杂志,2007:16(3):346-347.
[49]陈具堂.穴位注射治疗支气管哮喘73例[J].中国针灸,2007;27(1):75.
[50]张丽,汪兴洲.自血穴位注射治疗儿童支气管哮喘26例[J].浙江中医杂志,2007;42(7):419.
[51]郭燕.核酪针穴位注射为主治疗老年慢性支气管哮喘[J].山东中医志,2005;24(10):605.
[52]胡志光.针刺对支气管哮喘患者T细胞亚群和IL-4的影响[J].中国针灸,1999;(2):111.
[53]杜传海,杨军平,邱丽瑛.针刺治疗对哮喘患者血清IL-12、IL-4与IgE水平 的影响[J].山东中医杂志,2005;24(7):417-418.
[54]赖新生,李月梅,张家维.天灸对哮喘患者血清可溶性IL-2受体及T淋巴细胞亚群的影响[J].中国针灸,2000;(1):33-34.
[55]白晓红,邵功利,王雪峰.伏九贴膏防治小儿哮喘的临床研究探要[J].中医药学刊,2004;22(9):1637.
[56]付明举,黄红梅,吴华青,穴位埋线治疗支气管哮喘的临床研究[J].河北医学,2005;11(6):505-506.
[57]周丽莎,朱书秀,涂 乾.潜伏期天灸对哮喘模型大鼠的影响[J].陕西中医,2005;26(5):471-472.
[58]曾益新.肿瘤学[M],北京:人民卫生出版社,2003,第2版:428.
[59]冼励坚.《生物节律与时间医学》[M],郑州:郑州大学出版社,2003,267、137-141.
[60]王忠文,王午成.按时问经络诊断法治疗头痛的临床观察[J].天津中医学院学报,2002;2(9):34
[61]王虹,周华.子午流注治疗寻常性瘴疮疗效分析[J].贵阳医学院学报,2002,27(4):349 350
[62]李金香,蓝红勤.子午流注纳甲法针刺治疗脑梗塞30例疗效观察[J]针灸临床杂志,2000;16(7):29-30
[63]钟磊,刘维.子午流注合循经取穴治疗中风后遗症偏瘫观察[J].辽宁中医学院学报,2000;2(3):211
[64]迪亚拉.择时针法治疗冠心病患者ECG的研究[J].现代中医,1998;38(1):23-25
[65]胡九风.子午流注纳甲法治疗高血32例疗效观察[J].针灸临床杂志,2000;16(2):29-30
[66]张宏发 子午流注针刺法治疗胃痛的临床观察[J]针灸临床杂志,2001;7(3):28-29
[67]张岚,陈志强.《内经》的法时观与时间针灸学[J].中国中医基础医学杂志,1999;5(5):49-50.
[68]叶小雯,戴文军.点刺井穴治疗中风后手指活动不利27例疗效观察[J].中国中医急症,2005;14(8):740-741.
[69]刘英才.点刺井穴治愈指端痛1例[J].中国针灸,1998;18(5):292-293.
[70]孙淑芳,吕明庄,罗雄.井穴刺血法治疗肢端麻木的临床观察[J].中华中医药杂志,2005;20(7):447.
[71]刘赫.荥穴临床应用举隅[J].中国针灸,1996;16(12):27-28.
[72]高树中,赵联和,谭奇文,等.“病时间时甚者取之输”的临床应用体会[J].中国针灸,1998;18(7):431-432.
[73]应皎龙.合穴的特点与临床应用[J].针灸临床杂志,1997;13(8):37.
[74]张明,胡边,谢学勇.补母泻子法治疗肩周炎50例临床研究[J].中华医学研究杂志,2006;6(6):678-679
[75]董坚,臧岩.应用补母泻子法治疗肺脾气虚型过敏性鼻炎30例[J].包头医学院学报,2002;18(4):341342
[76]黄泳,姜雪梅,石娜,等.针刺足三里整复家兔体温昼夜节律[J].解放军预防医学杂志,2004;22(5):358-359.
[77]黄泳,宋开源.佐剂性关节炎家兔5一羟吲哚乙酸昼夜节律的观察及针刺对其之影响[J].成都中医药大学学报,1998;21(1):30-31.
[78]张小云,植爱容,陈捷.老年人冠心病心律失常及其昼夜节律的临床意义[J].广东医学,2006;427(4):533-535.
[79]瞿岳云.中医时间医学理论及应用[M],重庆:重庆出版社,1993,29.
[80]程士德.中医时间证治学纲要[M],北京:人民卫生出版社,1994,161.
[81]汪鲁莎,刘豫淑,罗惠平.纳子法针刺神门穴对心功能影响的观察[J].中国针灸,1997;5:264-265.
[82]朴联友,张学丽,刘颖.纳子法治疗定时疼痛42例[J].中国针灸,2003;23(2):83.
[83]刘佩云,郑彦立,闫立昱.浅谈“纳子法”的临床应用[J].上海针灸杂志,2004;23(7):33.
[84]林凤英.子午流注纳子法针刺治疗太阳头痛证的临床研究[J].哈尔滨医药,2008;28(6):39-41.
[85]蔡彦,陈文裕,陈创荣.纳子法电针治疗对哮喘模型豚鼠嗜酸性粒细胞凋亡的影响[J].广州中医药大学学报,2008;25(2):124-126.
[86]全国儿童哮喘防治协作组.中国城区儿童哮喘患病率调查[J].中华儿科杂志,2003;41:123-127.
[87]杨运刚,陈茂荣.T淋巴细胞在儿童支气管哮喘发生中的作用[J].实用儿科临床杂志,2003;18(8):615-616.
[88]赵顺英.哮喘发病机制研究进展[J].实用儿科临床杂志,2003;18(10):768-771.
[89]安肃英,孙宗芝,李根山.哮喘儿童血免疫球蛋白E、T细胞亚群与细胞因子动态观察及临床意义[J].实用儿科临床杂志,2004;19(2):117-119.
[90]肖玲莉.Th1/Th2免疫应答失衡及其影响因素[J].国际儿科学杂志,2006;33(6):399-402.
[91]金伯泉.细胞和分子免疫学[M],北京:科学出版社,2001,第2版:139-141.
[92]赵莉,麦贤弟,檀卫平,等.哮喘患儿IL-2、IL-12与IgE水平的初步研究[J].临床儿科杂志,2001;19(1):9-10.
[93]郁听,缪竞诚,严永东,等.哮喘患儿血清ECP、IL-4及INF-γ水平的变化及意义[J].临床检验杂志,2005;23(3):185.
[94]陈灏珠.实用内科学[M],北京:人民卫生出版社,1999,第10版:1397.
[95]Waslsh GM.Eosinophile apoptosis:Mechanisms and clinical relevance in asthmatic and allergic inflammation[J]BrJ Hacmatol,2000;106:61-67.
[96]周林福,殷凯生.三氧化二砷对哮喘豚鼠内嗜酸粒细胞凋亡的影响[J].中国中西医结合杂志,2002;22(4):292.
[97]An-Soo Jang,Inseon-S Choi,Soong Lee,et al.Bcl-2 expression in sputum eosinophils in patients with asthma[J].Thorax,2000;55:370.
[98]刘莉,杨炯,胡克,等.小剂量茶碱对哮喘患者诱导痰中嗜酸粒细胞Bcl-2、Bax 蛋白表达的影响[J].武汉大学学报,2004;25(2):133.
[99]Robinson DS.The role of the mastceil in asthma:induction of airway hyperresponsiveness by interaction with smooth muscle[J]Allergy Clin Immunol,2004;114(6):58-65.
[100]Bradding P.The role of the mast cell in asthma:a reassessment[J].Curt Opin Allerge clin Immunol,2003;3(1):45-50.
[101]Schwartz LB.Clinical utility of tryptase levels in systemic mastocytosis and associated hematologic disorders[J].Leuk Res,2001;25(7):553-562
[102]Bruce SB,William WB.Adances in mechanisms of allerge[J].Allerge Clin Immunol,2004,113(5) 868-875.
[103]谢华,何韶衡,迟秀丽等.哮喘患者血浆类胰蛋白酶、IL-8和嗜酸性粒细胞趋化因子水平与类糜蛋白酶活性测定及相关性分析[J].第四军医大学学报,2004;25(16):1502-1504.
[104]Cairns JA.Inhibittors of mast cell tryptase beta as therapeutics for the treatment of asthma and inflammatory disorders[J].Pulmonary Pharmacology&therapeutics,2005:18(1):55-66.
[105]Woodruff PG,Dolganov GM,Ferrando RE,et al.Hyperplasic of smooth muscle in mild to moderate asthma without changes in cell size or gene expression.Am J Respir Crit Care Med,2004:169:1001-1006.
[106]Munakata M.Airway remodeling and airway smooth muscle in asthma.Allergology Internationl,2006;55:235-243.
[107]Hoshino M,Nakamura Y,Sim JJ.Expression of growth factors and remodeling of the airway wall in bronchial asthma.Thorax,1998;53:21-27.
[108]Hoshino M,Takahashi M,takai Y,et al.Inhaled corticosteroids decrease subepithelial collagen deposition by modulation ofthe balance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in asthma.J Allergy Clin Immunol,1999:104:356-363.
[109]Holgate ST,Davies DE,Laekie PM,et al.Epithelial-mesenehymal interactions in the pathogenesis of asthma.[J]Allergy Clin Immuol,2000:105:193-204.
[110]梁红,谭平.哮喘患者Th1/Th2细胞因子水平变化[J].中国实验诊断学,2006;10(11):1350-1352.
[111]肖玲莉.Th1/Th2免疫应答失衡及其影响因素[J].国际儿科学杂志,2006;33(6):399-402.
[112]杨远,张祖胎,金淑贤等.糖皮质激素对哮喘患者IL-4mRNA与IL-5mRNA表达的影响[J].江苏医药,2001;27(7):489-491.
[113]刘又宁.浅谈支气管哮喘治疗的几个问题[J].中华内科杂志,1996;4(35):219.
[114]张红雨.我院呼吸科哮喘治疗用药100例分析[J].中国药师,2003;6(11):728-729.
[115]张祖贻.哮喘的糖皮质激素治疗[J].医师进修杂志,1996;11(19):2.
[116]陈爱欢,钟南山.低剂量丙酸倍氯松吸入对轻度哮喘儿童气道高反应性的影响[J].临床儿科杂志,2000;18(2):69-71.
[117]中华医学呼吸病学分会.支气管哮喘防治指南[J].中华结核和呼吸杂志,1997;5(20):261.
[118]洪建国,王乃礼.哮喘的吸入治疗和吸入装置[J].临床儿科杂志,2000;18(3):185-186
[119]陈新谦,金有豫,汤光.新编药物学[M],北京:人民卫生出版社,2007,第16版:434.
[120]Rabek F,Jorres R,Nowak D,et al.Comparison of the effects of salmererol and formoterol on airway tone and responsiveness over 24 hours in bronchial asthma[J].Am Rev Respir Dis,1993;147(6):1436-1441.
[121]Corren J,Speetor S,Fuher L,et al Effects of zafirlukast up-on clinical,physiologic,and inflammatory response to natural cat allergen exposure.Ann Allergy Asthma Immund,2001;87:211-217.
[122]Vaquefizo MJ,Casan P,Castillo J,et al.Effects of motelukast added to inhaled budesonide on control of mild to moderate asthma.Thorax,2002:58:204-210.
[123]刘敬.孟鲁司特治疗哮喘疗效观察[J].中国社区医生(医学专业半月刊),2008; 10(9):24.
[124]吴永红.哮喘患儿对白三烯受体拮抗剂反应临床研究[D].四川大学,2007.
[125]李晓萍,巨春蓉.对茶碱的再认识[J].中国医院药学杂志,2005;25(9):870-871.
[126]Lim S,Tomita K,Carrmor G,et al.Low-dose theophylline reduce eosinophillic inflammation but not exhaled nieric oxide in mild asthma[J].Am J Respir Crit Care Med,2001;164(2):273-276.
[127]Ukena D,Harnest U,Sakalauskas R,et al.Comparison of addition of theophylline to inhaled steroid with doubling of the dose of inhaled steroid in asthma[J].Eur Respir J,1997;10(12):2754-2760
[128]李志奎,王长征,钱挂生.氨萘碱对体外嗜酸性粒细胞凋亡及Fas mRNA表达的影响[J].中国药理学通报,2001;17(5):543-545.
[129]童亮.氨茶碱治疗小儿喘息临床体会[J].临床儿科杂志,1998;16(1):9-10.
[130]吴健,刘启良.脱敏治疗哮喘对嗜酸粒细胞和T淋巴细胞功能的影[J].实用医学杂志,1999;15(3):247.
[131]李明华.哮喘病的脱敏治疗[J].中国临床医生,2004;32(2):12-13.
[132]梅芬娥,周孝贞.脱敏治疗支气管哮喘的疗效观察[J].广西医学,2005,;27(1):94-95
[133]LINGNAU K,HOEHN P,KERDINE S,et al.IL-4 in combination with TGF favors alternation path-way of TH1 development independent of IL-12.J Immunol,1998;161(9):4709.
[134]OShea JJ,Gadina M,Sehreiher RD.Cytokines signaling in 2002:new surprise in the JAN / STAT pathway.Cell,2002;109(Suppl):S121.
[135]Nelms K,Keegan J,Zamorano J,et al.The IL-4 receptor:signaling mechanism and biologic functions.Annu Rev Immunol,1999;17:701-747.
[136]Borish LC,Steinke JW.Cytokines and chemokines.J Allergy Clin Immunol,2003;111(2):s460-475
[137]张开明,董峰,李佩珍,等.荨麻疹患者白介素2、白介素2受体及T细胞亚群改变[J].中华皮肤科杂志,1994:27(6):358-359.
[138]虞海燕,岑建萍,高锦程.慢性荨麻疹患者IL-4、IL-6及IFN-γ的检测[J].临床皮肤科杂志,1998;27(6):361-362.
[139]刘宝军,王青,刘超,等.荨麻疹患者外周血单个核细胞产生IL-4、IL-10及IFN-γ水平及意义[J].临床皮肤科杂志,2002;31(2)87-88.
[140]Hashimoto Set al.J Allergy Clin Immunol,2001;107:1001-1008
[141]Wen FQ,et al.Am J Respir Cell Mol Biol,2002;26:484-490.
[142]Blease K,et al.J Immunol,2001;166:5219-5224.
[143]Henderson WR,et al.Am J Respir Crit Care Med,2002;165:108-116.
[144]Elias JA.Am J Respir Crit Care Med,2000;161:S168-171.
[145]Pare PD,Roberts CR,Bai TR,et al.The functional consequences of airway remodeling in asthma.Monaldi Arch Chest Dis,1997;52:589-596.
[146]James AL,Pare PD,Hogg IC,et al.The use of internal perimeter to compare airway size and to calculate smooth muscle shortening.AM Rev Respir Dis,1988;138:136-136.
[147]Panettiier RA.AM J Respir Crit Care Med,1998;158:S133-S140.
[148]Elias JA,et al.Am J Respir Crit Care Med,2000;161:5168-5171
[149]Roberts CR.Chest,1995;107:111S-117S.
[150]Roche WR,et al.Lancet,1989;520-524.
[151]Amishima M,et al.Am J Respir Crit Care Med,1989,157:1907-1912.
[152]Wiggs BR,Bosken F,Pare PD,et al.A model of airway narrowing in asthma and in chronic obstructive pulmonary dieases.Am Rev Respir Dis,1992;145:1251-1259.
[153]Elias JA.Am J Respir Crit Care Med,2000;161:S168-171
[154]Johnson PR,et al.Am J Respir Crit Care Med,2001;164:474-477.
[155]王文娟,张孔.哮喘患者IL-13、IL-4水平与哮喘控制的关系[J].国际内科学杂志,2008;7(35):373-375.
[156]Nathan RA,Sorkness CA,Kosinski M.et al.Deveopment of the asthma contml test:A survey for assessing asthma control.J Allergy Cin Immunol,2004;113:59-65.
[157]李志平,彭丽红,郭禹标,等.哮喘控制测试在中国应用的可行性研究.中国医学工程,2007;2(15):160-162.
[158]夏云丽,查小芳.哮喘控制测试(ACT)的临床应用[J].临床肺科杂志,2008;10(13):1366.
[159]WHO/NHLBI Workshop Repo Global initiative for asthma management and prevention,maryhaland national institute of health.National Heart long and Blood institute,2006:20-70.
[160]黄寒,王涛,易红玲.舒利迭治疗儿童中重度哮喘早期PEF值变化观察[J].医学临床研究,2008;25:1630-1632.
[161]李善群,钮善福,聂莉.哮喘症状评分及PEF评价普鲁司特治疗支气管哮喘的临床疗效[J].中国临床医学,2008;3(15):318-321.
[162]马传江,田萍.《难经·六十八难》五输穴主治管见[J].山东中医药大学学报, 1998:22(6):421.
[163]李明霞.五输穴主治规律初探[J].北京中医药大学学报,1996,19(2):51-53.
[164]赵百孝.从输穴的主治特点谈五输穴原理[J].中国针灸,2004;24(6):417-419.
[165]王乾顺.合穴特点与临床应用体会[J].实用中医药杂志,2000;16(12):39.
[166]宋立中,张泉玲.辰时、酉时电针对脑血栓患者TXB2、PGfla的影响[J].针灸临床杂志,2007;12(23):25-28.
[167]宋为民.祖国医学对时间生物学的贡献[J].南京中医学院学报,1982;(3):55-58.
[168]胡剑北.中医时间医学[M],安微:安微科学技术出版社,1990,53-54.
[169]姚成增,胡剑北,程宜福.中医“肾”的时间医学研究概况[J].皖南医学院学报,2003;22(3):223-224.
[170]朱士杰.中国干支纪时研究与中医学[M],安微:安微科学技术出版社,1992,43-45.
[171]Mclintire JJ,Umetsu SE,Akbari O,et al.Identification of Tapr(an airway hyperreactivity regulatory locus)and the linked Tim gene family[J].Nat Immunol,2001;2(12):1109-1116.
[172]Kuchroo VK,Umntsu DT,Dekruff RH,et al.The TIM gene family:emerging roles in immunity and disease[J],Nat Rev Immunol,2003;3(60):454-462.
[173]Whittaker PA.Gene for asthma:much ado about nothing?[J].Curr Opin Pharmacol,2003;3(3):212-219.
[174]Monney L,Sabatos CA,Gaglia JL,et al.Thl-specific cell surface protine Tim-3 regulates macrophage activation and severity of an autoimmune disease [J].nature,2002;415(6871):536-541
[175]Sabatos CA,Chakravati S,Cha E,et al.Interaction of Tim-3 and Tim-3Ligand regulates T helper type 1 responses and induction of peripheral tolerance[J].Nat Immunol,2003:4(11):1102-1110.
[176]Graves PE,Siroux V,Guerra S,et al.Association of atopy and eczema with polymorphisms in T-cell immunoglobulin domain and mucin domain-IL-2-inducible T-cell kinase gene cluster in chro-mosome 5q33[J].J Allergy Clin Immunol,2005;116(3):650-656.
[177]Gielen AW,Lobell A,lidman O,et al.Expression of T cell immunoglobulin and mucin domain containing molecules-1 and -3(TIM-1 and -3) in the rat nervous and immune systems[J].J Neuroimmunol,2005;164(1/2):93-104.
[178]Meyers JH,Sabatos CA,Chakravarti S,et al.The TIM gene family regulates autoimmune and allergic dieaese[J].Trends Mol Med,2005;11(8):362-369.
[179]Van de Weyer PS,Muehlfeit M,Klose C,et al.A highly conserved tyrosine of Tim-3 is phosphorylated upon stimulation by its ligand galectin-9[J].Biochem Biophys Res Commun,2006:351(2):571-576.
[180]Gao PS,Mathias RA,Plunkett B,et al.Genetic variants of the T-cell immunoglobulin mucin 1 but not the T-cell immunoglobulin mucin 3 gene are associated with asthma in an African American population[J].J Allergy Clin Immunol,2005;115(5):982-988.
[181]Chae SC,Park YR,Lee YC,et al.The association of TIM-3 gene polymorphism with atopic disease in Korean population[J].Hum Immunol,2004;65(7):1427-1431.
[182]胡天丽,崔天盆,张才成,等.湖北地区汉族变应性哮喘患儿Tim-3启动子区基因多态性研究[J].中华检验医学杂志,2006;29(2):125-127.
[183]沈自尹.中西医结合防治支气管哮喘的探讨[J].中国中西医结合杂志,1995;15(7):426.
[184]彭素岚,白雪,罗家红,等.中西医结合治疗支气管哮喘缓解期患者免疫功能的变化[J].中国中西医结合急救杂志,1999;6(11):510.
[186]宋康,骆仙芳.支气管哮喘治疗的研究进展[J].浙江中医学院学报,2002;26(1):71.
[186]钟历勇,沈自尹,蔡定芳,等.补肾健脾活血三类复方时下丘脑-垂体-肾上腺-胸腺轴及CRF基因表达的影响[J].中国中西医结合杂志,1997;17(1):39.
[2]杨贵贞.医学免疫学[M],北京:高等教育出版社,2003,72-75.
[3]O' shea JJ,Gadina M,Schreiber RD.Cytokines signaling in 2002:new surprise in the JAK/STAT pathway.Cell,2002;109(suppl):S121.
[4]Holgate ST.airway inflammation and remodeling in asthma:current concepts.Mol Biotechnol,2002;22(2):179.
[5]Davies DE,Wicks J,Powell RM,et al.airway remodeling in asthma:new insights.J Allergy Clin Immunol,2003:111(20):215.
[6]Payne DN.Nitric oxide in allergic airway inflammation.Curr Opin Allergy Clin Immunol,2003;3(2):133-137.
[7]nogate SP,Koskinen A,Matthae KI,et al.interleukin-5 producing CD4+Tcells play a pivotal role in aeroallergen-induced eosinophilia brochial hypperreactivity and lung damage in mice.AM J Respir Crit Care,1998;157(1):210-218.
[8]Nelms K,Keegan J,Zamorano J,et al.The IL-4 receptor:signaling mechanisms and biologic functions.Annu Rev Immunol,1999;17:701-747.
[9]胡志光.针刺对支气管哮喘患者T细胞亚群和IL-4的影响[J].中国针灸,1999;(2):111.
[10]杜传海,杨军平,邱丽瑛.针刺治疗对哮喘患者血清IL-12、IL-4与IgE水平的影响[J].山东中医杂志,2005;24(7):417-418.
[11]赖新生,李月梅,张家维.天灸对哮喘患者血清可溶性IL-2受体及T淋巴细胞亚群的影响[J].中国针灸,2000;(1):33-34.
[12]白晓红,邵功利,王雪峰.伏九贴膏防治小儿哮喘的临床研究探要[J].中医药学刊,2004;22(9):1637.
[13]付明举,黄红梅,吴华青,穴位埋线治疗支气管哮喘的临床研究[J].河北医学,2005;11(6):505-506.
[14]周丽莎,朱书秀,涂 乾.潜伏期天灸对哮喘模型大鼠的影响[J].陕西中医,2005;26(5):471-472.
[15]刘冠军,顾光.子午流注与针灸推转盘[M],上海:上海科学技术出版社,1983:5-7.
[16]承淡安,陈璧琉,徐惜年.子午流注针法[M],南京:江苏人民出版社,1958:1 -3.
[17]吴槕仙.子午流注说难[M],成都:四川人民出版社,1958:10-13.
[18]胡国俊.哮喘治痰一得[J].中医杂志,1997;38(12):723.
[19]宋涌文.温肾健脾祛痰法控制支气管哮喘复发30例[J].浙江中医杂志,1998;33(1):2822.
[20]陈玉龙,邱晓荣,尹超英,等.从瘀血谈支气管哮喘证治[J].河南中医药学刊,1998:13(1):19.
[21]方永奇.痰证的血液循环特征初探[J].湖北中医杂志,1993;14(6):33.
[22]许德金.丹参防治支气管哮喘的临床及血液流变学的研究观察[J].江苏中医,1992:13(9):38.
[23]曲文华,清热化痰佐以补肾温阳治疗热哮36例[J],山东中医杂志,1996;15(2):62.
[24]许得盛,沈自尹,王文健,等.补肾健脾法在防治重症哮喘中的作用探讨[J].中国中西医结合杂志,1997;17(10):584.
[25]沈自尹.中西医结台防治支气管哮喘的探讨[J].中国中西医结合杂志,1995;15(7):426.
[26]董桂青.苓甘五昧姜辛汤合二陈汤加减治疗咳嗽变异性哮60例[J].国医论坛,2008;23(5):24-25.
[27]张宾.平气散加减治疗哮喘54例[J].实用中医内科杂志,2008;22(9):19-20.
[28]杨静,陈雅民.宣肺化瘀汤治疗小儿哮喘50例[J].中国中医急症,2008;17(9):1291.
[29]张文彭.针刺对支气管哮喘患者临床症状与肺功能的影响[J].中国针灸,2006;26(11):763-767.
[30]孙爱娟.针刺治疗哮喘的临床观察[J].Chinese Journal of the Practical Chinese with Modern Medicine,2007;201(7):588.
[31]刘富生.针灸三联法治疗哮喘30例[J].实用中医药杂志,2006;22(1):24-25.
[32]王又平,高丽华.针灸治疗哮喘50例临床观察[J].光明中医,2008;23(1):23-24.
[33]胡伟勇.子年流注针法治疗支气管哮喘65例临床观察[J].江西中医学院学报,1995;7(4):11.
[34]刘宏.化脓灸治疗外感性支气管哮喘发作期疗效观察[J].辽宁中医杂志,2005;32(1):55.
[35]陆亚康.“三伏灸”防治支气管哮喘117例临床观察[J].针灸临床杂志,1999; 15(1):29-31.
[36]刘明清,黄启嵩.化脓灸治疗支气管哮喘的临床疗效观察[J].中国针灸,2002;22(8):537-539.
[37]米建平,刘炳权.天灸疗法防治支气管哮喘18l例疗效观察[J].新中医,2005;37(2):61-62.
[38]李磊,高尚轸,王忠英.背俞穴埋线疗法治疗支气管哮喘临床观察[J].针灸临床杂志,2005;21(6):41.
[39]张琳,赵晓晨,靳聪妮.埋线疗法治疗支气管哮喘246例临床观察[J].山西中医学院院报,2007;8(4):32-33.
[40]张鲜萍.穴位埋线法治疗支气管哮喘36例临床观察[J].山西中医,2006;22(6):33.
[41]周小鸿,陈立生.穴位十字形埋线治疗支气管哮喘56例疗效观察[J].新中医,2007;39(8):65-66.
[42]韩慧敏.冬病夏治穴位敷贴法治疗老年哮喘缓解期[J].Chinese Journal of RehabIlitation,2008;23(4):240.
[43]赵卫国,吕素君.穴位敷贴治疗支气管哮喘56例[J].中国中医急症,2008;17(1):74.
[44]袁保丰,秦黎虹,张建华.穴位贴敷次数对缓解期哮喘患者肺功能的影响[J].云南中医中药杂志,2007;28(9):9.
[45]张舒雁,马泽云.穴位贴敷法防治哮喘88例[J].中华中医药学刊,2007;25(3):547.
[46]毕关芬.药物穴位贴敷治疗小儿支气管哮喘160例[J].实用中西医结合临床,2005;5(5):54-55.
[47]高洪英,徐建勇.痰热清穴位注射治疗支气管哮喘52例[J].时珍国医国药,2006;17(9):1754-1755.
[48]项春福.穴位注射治疗支气管哮喘42例[J].现代中西医结合杂志,2007:16(3):346-347.
[49]陈具堂.穴位注射治疗支气管哮喘73例[J].中国针灸,2007;27(1):75.
[50]张丽,汪兴洲.自血穴位注射治疗儿童支气管哮喘26例[J].浙江中医杂志,2007;42(7):419.
[51]郭燕.核酪针穴位注射为主治疗老年慢性支气管哮喘[J].山东中医志,2005;24(10):605.
[52]胡志光.针刺对支气管哮喘患者T细胞亚群和IL-4的影响[J].中国针灸,1999;(2):111.
[53]杜传海,杨军平,邱丽瑛.针刺治疗对哮喘患者血清IL-12、IL-4与IgE水平 的影响[J].山东中医杂志,2005;24(7):417-418.
[54]赖新生,李月梅,张家维.天灸对哮喘患者血清可溶性IL-2受体及T淋巴细胞亚群的影响[J].中国针灸,2000;(1):33-34.
[55]白晓红,邵功利,王雪峰.伏九贴膏防治小儿哮喘的临床研究探要[J].中医药学刊,2004;22(9):1637.
[56]付明举,黄红梅,吴华青,穴位埋线治疗支气管哮喘的临床研究[J].河北医学,2005;11(6):505-506.
[57]周丽莎,朱书秀,涂 乾.潜伏期天灸对哮喘模型大鼠的影响[J].陕西中医,2005;26(5):471-472.
[58]曾益新.肿瘤学[M],北京:人民卫生出版社,2003,第2版:428.
[59]冼励坚.《生物节律与时间医学》[M],郑州:郑州大学出版社,2003,267、137-141.
[60]王忠文,王午成.按时问经络诊断法治疗头痛的临床观察[J].天津中医学院学报,2002;2(9):34
[61]王虹,周华.子午流注治疗寻常性瘴疮疗效分析[J].贵阳医学院学报,2002,27(4):349 350
[62]李金香,蓝红勤.子午流注纳甲法针刺治疗脑梗塞30例疗效观察[J]针灸临床杂志,2000;16(7):29-30
[63]钟磊,刘维.子午流注合循经取穴治疗中风后遗症偏瘫观察[J].辽宁中医学院学报,2000;2(3):211
[64]迪亚拉.择时针法治疗冠心病患者ECG的研究[J].现代中医,1998;38(1):23-25
[65]胡九风.子午流注纳甲法治疗高血32例疗效观察[J].针灸临床杂志,2000;16(2):29-30
[66]张宏发 子午流注针刺法治疗胃痛的临床观察[J]针灸临床杂志,2001;7(3):28-29
[67]张岚,陈志强.《内经》的法时观与时间针灸学[J].中国中医基础医学杂志,1999;5(5):49-50.
[68]叶小雯,戴文军.点刺井穴治疗中风后手指活动不利27例疗效观察[J].中国中医急症,2005;14(8):740-741.
[69]刘英才.点刺井穴治愈指端痛1例[J].中国针灸,1998;18(5):292-293.
[70]孙淑芳,吕明庄,罗雄.井穴刺血法治疗肢端麻木的临床观察[J].中华中医药杂志,2005;20(7):447.
[71]刘赫.荥穴临床应用举隅[J].中国针灸,1996;16(12):27-28.
[72]高树中,赵联和,谭奇文,等.“病时间时甚者取之输”的临床应用体会[J].中国针灸,1998;18(7):431-432.
[73]应皎龙.合穴的特点与临床应用[J].针灸临床杂志,1997;13(8):37.
[74]张明,胡边,谢学勇.补母泻子法治疗肩周炎50例临床研究[J].中华医学研究杂志,2006;6(6):678-679
[75]董坚,臧岩.应用补母泻子法治疗肺脾气虚型过敏性鼻炎30例[J].包头医学院学报,2002;18(4):341342
[76]黄泳,姜雪梅,石娜,等.针刺足三里整复家兔体温昼夜节律[J].解放军预防医学杂志,2004;22(5):358-359.
[77]黄泳,宋开源.佐剂性关节炎家兔5一羟吲哚乙酸昼夜节律的观察及针刺对其之影响[J].成都中医药大学学报,1998;21(1):30-31.
[78]张小云,植爱容,陈捷.老年人冠心病心律失常及其昼夜节律的临床意义[J].广东医学,2006;427(4):533-535.
[79]瞿岳云.中医时间医学理论及应用[M],重庆:重庆出版社,1993,29.
[80]程士德.中医时间证治学纲要[M],北京:人民卫生出版社,1994,161.
[81]汪鲁莎,刘豫淑,罗惠平.纳子法针刺神门穴对心功能影响的观察[J].中国针灸,1997;5:264-265.
[82]朴联友,张学丽,刘颖.纳子法治疗定时疼痛42例[J].中国针灸,2003;23(2):83.
[83]刘佩云,郑彦立,闫立昱.浅谈“纳子法”的临床应用[J].上海针灸杂志,2004;23(7):33.
[84]林凤英.子午流注纳子法针刺治疗太阳头痛证的临床研究[J].哈尔滨医药,2008;28(6):39-41.
[85]蔡彦,陈文裕,陈创荣.纳子法电针治疗对哮喘模型豚鼠嗜酸性粒细胞凋亡的影响[J].广州中医药大学学报,2008;25(2):124-126.
[86]全国儿童哮喘防治协作组.中国城区儿童哮喘患病率调查[J].中华儿科杂志,2003;41:123-127.
[87]杨运刚,陈茂荣.T淋巴细胞在儿童支气管哮喘发生中的作用[J].实用儿科临床杂志,2003;18(8):615-616.
[88]赵顺英.哮喘发病机制研究进展[J].实用儿科临床杂志,2003;18(10):768-771.
[89]安肃英,孙宗芝,李根山.哮喘儿童血免疫球蛋白E、T细胞亚群与细胞因子动态观察及临床意义[J].实用儿科临床杂志,2004;19(2):117-119.
[90]肖玲莉.Th1/Th2免疫应答失衡及其影响因素[J].国际儿科学杂志,2006;33(6):399-402.
[91]金伯泉.细胞和分子免疫学[M],北京:科学出版社,2001,第2版:139-141.
[92]赵莉,麦贤弟,檀卫平,等.哮喘患儿IL-2、IL-12与IgE水平的初步研究[J].临床儿科杂志,2001;19(1):9-10.
[93]郁听,缪竞诚,严永东,等.哮喘患儿血清ECP、IL-4及INF-γ水平的变化及意义[J].临床检验杂志,2005;23(3):185.
[94]陈灏珠.实用内科学[M],北京:人民卫生出版社,1999,第10版:1397.
[95]Waslsh GM.Eosinophile apoptosis:Mechanisms and clinical relevance in asthmatic and allergic inflammation[J]BrJ Hacmatol,2000;106:61-67.
[96]周林福,殷凯生.三氧化二砷对哮喘豚鼠内嗜酸粒细胞凋亡的影响[J].中国中西医结合杂志,2002;22(4):292.
[97]An-Soo Jang,Inseon-S Choi,Soong Lee,et al.Bcl-2 expression in sputum eosinophils in patients with asthma[J].Thorax,2000;55:370.
[98]刘莉,杨炯,胡克,等.小剂量茶碱对哮喘患者诱导痰中嗜酸粒细胞Bcl-2、Bax 蛋白表达的影响[J].武汉大学学报,2004;25(2):133.
[99]Robinson DS.The role of the mastceil in asthma:induction of airway hyperresponsiveness by interaction with smooth muscle[J]Allergy Clin Immunol,2004;114(6):58-65.
[100]Bradding P.The role of the mast cell in asthma:a reassessment[J].Curt Opin Allerge clin Immunol,2003;3(1):45-50.
[101]Schwartz LB.Clinical utility of tryptase levels in systemic mastocytosis and associated hematologic disorders[J].Leuk Res,2001;25(7):553-562
[102]Bruce SB,William WB.Adances in mechanisms of allerge[J].Allerge Clin Immunol,2004,113(5) 868-875.
[103]谢华,何韶衡,迟秀丽等.哮喘患者血浆类胰蛋白酶、IL-8和嗜酸性粒细胞趋化因子水平与类糜蛋白酶活性测定及相关性分析[J].第四军医大学学报,2004;25(16):1502-1504.
[104]Cairns JA.Inhibittors of mast cell tryptase beta as therapeutics for the treatment of asthma and inflammatory disorders[J].Pulmonary Pharmacology&therapeutics,2005:18(1):55-66.
[105]Woodruff PG,Dolganov GM,Ferrando RE,et al.Hyperplasic of smooth muscle in mild to moderate asthma without changes in cell size or gene expression.Am J Respir Crit Care Med,2004:169:1001-1006.
[106]Munakata M.Airway remodeling and airway smooth muscle in asthma.Allergology Internationl,2006;55:235-243.
[107]Hoshino M,Nakamura Y,Sim JJ.Expression of growth factors and remodeling of the airway wall in bronchial asthma.Thorax,1998;53:21-27.
[108]Hoshino M,Takahashi M,takai Y,et al.Inhaled corticosteroids decrease subepithelial collagen deposition by modulation ofthe balance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in asthma.J Allergy Clin Immunol,1999:104:356-363.
[109]Holgate ST,Davies DE,Laekie PM,et al.Epithelial-mesenehymal interactions in the pathogenesis of asthma.[J]Allergy Clin Immuol,2000:105:193-204.
[110]梁红,谭平.哮喘患者Th1/Th2细胞因子水平变化[J].中国实验诊断学,2006;10(11):1350-1352.
[111]肖玲莉.Th1/Th2免疫应答失衡及其影响因素[J].国际儿科学杂志,2006;33(6):399-402.
[112]杨远,张祖胎,金淑贤等.糖皮质激素对哮喘患者IL-4mRNA与IL-5mRNA表达的影响[J].江苏医药,2001;27(7):489-491.
[113]刘又宁.浅谈支气管哮喘治疗的几个问题[J].中华内科杂志,1996;4(35):219.
[114]张红雨.我院呼吸科哮喘治疗用药100例分析[J].中国药师,2003;6(11):728-729.
[115]张祖贻.哮喘的糖皮质激素治疗[J].医师进修杂志,1996;11(19):2.
[116]陈爱欢,钟南山.低剂量丙酸倍氯松吸入对轻度哮喘儿童气道高反应性的影响[J].临床儿科杂志,2000;18(2):69-71.
[117]中华医学呼吸病学分会.支气管哮喘防治指南[J].中华结核和呼吸杂志,1997;5(20):261.
[118]洪建国,王乃礼.哮喘的吸入治疗和吸入装置[J].临床儿科杂志,2000;18(3):185-186
[119]陈新谦,金有豫,汤光.新编药物学[M],北京:人民卫生出版社,2007,第16版:434.
[120]Rabek F,Jorres R,Nowak D,et al.Comparison of the effects of salmererol and formoterol on airway tone and responsiveness over 24 hours in bronchial asthma[J].Am Rev Respir Dis,1993;147(6):1436-1441.
[121]Corren J,Speetor S,Fuher L,et al Effects of zafirlukast up-on clinical,physiologic,and inflammatory response to natural cat allergen exposure.Ann Allergy Asthma Immund,2001;87:211-217.
[122]Vaquefizo MJ,Casan P,Castillo J,et al.Effects of motelukast added to inhaled budesonide on control of mild to moderate asthma.Thorax,2002:58:204-210.
[123]刘敬.孟鲁司特治疗哮喘疗效观察[J].中国社区医生(医学专业半月刊),2008; 10(9):24.
[124]吴永红.哮喘患儿对白三烯受体拮抗剂反应临床研究[D].四川大学,2007.
[125]李晓萍,巨春蓉.对茶碱的再认识[J].中国医院药学杂志,2005;25(9):870-871.
[126]Lim S,Tomita K,Carrmor G,et al.Low-dose theophylline reduce eosinophillic inflammation but not exhaled nieric oxide in mild asthma[J].Am J Respir Crit Care Med,2001;164(2):273-276.
[127]Ukena D,Harnest U,Sakalauskas R,et al.Comparison of addition of theophylline to inhaled steroid with doubling of the dose of inhaled steroid in asthma[J].Eur Respir J,1997;10(12):2754-2760
[128]李志奎,王长征,钱挂生.氨萘碱对体外嗜酸性粒细胞凋亡及Fas mRNA表达的影响[J].中国药理学通报,2001;17(5):543-545.
[129]童亮.氨茶碱治疗小儿喘息临床体会[J].临床儿科杂志,1998;16(1):9-10.
[130]吴健,刘启良.脱敏治疗哮喘对嗜酸粒细胞和T淋巴细胞功能的影[J].实用医学杂志,1999;15(3):247.
[131]李明华.哮喘病的脱敏治疗[J].中国临床医生,2004;32(2):12-13.
[132]梅芬娥,周孝贞.脱敏治疗支气管哮喘的疗效观察[J].广西医学,2005,;27(1):94-95
[133]LINGNAU K,HOEHN P,KERDINE S,et al.IL-4 in combination with TGF favors alternation path-way of TH1 development independent of IL-12.J Immunol,1998;161(9):4709.
[134]OShea JJ,Gadina M,Sehreiher RD.Cytokines signaling in 2002:new surprise in the JAN / STAT pathway.Cell,2002;109(Suppl):S121.
[135]Nelms K,Keegan J,Zamorano J,et al.The IL-4 receptor:signaling mechanism and biologic functions.Annu Rev Immunol,1999;17:701-747.
[136]Borish LC,Steinke JW.Cytokines and chemokines.J Allergy Clin Immunol,2003;111(2):s460-475
[137]张开明,董峰,李佩珍,等.荨麻疹患者白介素2、白介素2受体及T细胞亚群改变[J].中华皮肤科杂志,1994:27(6):358-359.
[138]虞海燕,岑建萍,高锦程.慢性荨麻疹患者IL-4、IL-6及IFN-γ的检测[J].临床皮肤科杂志,1998;27(6):361-362.
[139]刘宝军,王青,刘超,等.荨麻疹患者外周血单个核细胞产生IL-4、IL-10及IFN-γ水平及意义[J].临床皮肤科杂志,2002;31(2)87-88.
[140]Hashimoto Set al.J Allergy Clin Immunol,2001;107:1001-1008
[141]Wen FQ,et al.Am J Respir Cell Mol Biol,2002;26:484-490.
[142]Blease K,et al.J Immunol,2001;166:5219-5224.
[143]Henderson WR,et al.Am J Respir Crit Care Med,2002;165:108-116.
[144]Elias JA.Am J Respir Crit Care Med,2000;161:S168-171.
[145]Pare PD,Roberts CR,Bai TR,et al.The functional consequences of airway remodeling in asthma.Monaldi Arch Chest Dis,1997;52:589-596.
[146]James AL,Pare PD,Hogg IC,et al.The use of internal perimeter to compare airway size and to calculate smooth muscle shortening.AM Rev Respir Dis,1988;138:136-136.
[147]Panettiier RA.AM J Respir Crit Care Med,1998;158:S133-S140.
[148]Elias JA,et al.Am J Respir Crit Care Med,2000;161:5168-5171
[149]Roberts CR.Chest,1995;107:111S-117S.
[150]Roche WR,et al.Lancet,1989;520-524.
[151]Amishima M,et al.Am J Respir Crit Care Med,1989,157:1907-1912.
[152]Wiggs BR,Bosken F,Pare PD,et al.A model of airway narrowing in asthma and in chronic obstructive pulmonary dieases.Am Rev Respir Dis,1992;145:1251-1259.
[153]Elias JA.Am J Respir Crit Care Med,2000;161:S168-171
[154]Johnson PR,et al.Am J Respir Crit Care Med,2001;164:474-477.
[155]王文娟,张孔.哮喘患者IL-13、IL-4水平与哮喘控制的关系[J].国际内科学杂志,2008;7(35):373-375.
[156]Nathan RA,Sorkness CA,Kosinski M.et al.Deveopment of the asthma contml test:A survey for assessing asthma control.J Allergy Cin Immunol,2004;113:59-65.
[157]李志平,彭丽红,郭禹标,等.哮喘控制测试在中国应用的可行性研究.中国医学工程,2007;2(15):160-162.
[158]夏云丽,查小芳.哮喘控制测试(ACT)的临床应用[J].临床肺科杂志,2008;10(13):1366.
[159]WHO/NHLBI Workshop Repo Global initiative for asthma management and prevention,maryhaland national institute of health.National Heart long and Blood institute,2006:20-70.
[160]黄寒,王涛,易红玲.舒利迭治疗儿童中重度哮喘早期PEF值变化观察[J].医学临床研究,2008;25:1630-1632.
[161]李善群,钮善福,聂莉.哮喘症状评分及PEF评价普鲁司特治疗支气管哮喘的临床疗效[J].中国临床医学,2008;3(15):318-321.
[162]马传江,田萍.《难经·六十八难》五输穴主治管见[J].山东中医药大学学报, 1998:22(6):421.
[163]李明霞.五输穴主治规律初探[J].北京中医药大学学报,1996,19(2):51-53.
[164]赵百孝.从输穴的主治特点谈五输穴原理[J].中国针灸,2004;24(6):417-419.
[165]王乾顺.合穴特点与临床应用体会[J].实用中医药杂志,2000;16(12):39.
[166]宋立中,张泉玲.辰时、酉时电针对脑血栓患者TXB2、PGfla的影响[J].针灸临床杂志,2007;12(23):25-28.
[167]宋为民.祖国医学对时间生物学的贡献[J].南京中医学院学报,1982;(3):55-58.
[168]胡剑北.中医时间医学[M],安微:安微科学技术出版社,1990,53-54.
[169]姚成增,胡剑北,程宜福.中医“肾”的时间医学研究概况[J].皖南医学院学报,2003;22(3):223-224.
[170]朱士杰.中国干支纪时研究与中医学[M],安微:安微科学技术出版社,1992,43-45.
[171]Mclintire JJ,Umetsu SE,Akbari O,et al.Identification of Tapr(an airway hyperreactivity regulatory locus)and the linked Tim gene family[J].Nat Immunol,2001;2(12):1109-1116.
[172]Kuchroo VK,Umntsu DT,Dekruff RH,et al.The TIM gene family:emerging roles in immunity and disease[J],Nat Rev Immunol,2003;3(60):454-462.
[173]Whittaker PA.Gene for asthma:much ado about nothing?[J].Curr Opin Pharmacol,2003;3(3):212-219.
[174]Monney L,Sabatos CA,Gaglia JL,et al.Thl-specific cell surface protine Tim-3 regulates macrophage activation and severity of an autoimmune disease [J].nature,2002;415(6871):536-541
[175]Sabatos CA,Chakravati S,Cha E,et al.Interaction of Tim-3 and Tim-3Ligand regulates T helper type 1 responses and induction of peripheral tolerance[J].Nat Immunol,2003:4(11):1102-1110.
[176]Graves PE,Siroux V,Guerra S,et al.Association of atopy and eczema with polymorphisms in T-cell immunoglobulin domain and mucin domain-IL-2-inducible T-cell kinase gene cluster in chro-mosome 5q33[J].J Allergy Clin Immunol,2005;116(3):650-656.
[177]Gielen AW,Lobell A,lidman O,et al.Expression of T cell immunoglobulin and mucin domain containing molecules-1 and -3(TIM-1 and -3) in the rat nervous and immune systems[J].J Neuroimmunol,2005;164(1/2):93-104.
[178]Meyers JH,Sabatos CA,Chakravarti S,et al.The TIM gene family regulates autoimmune and allergic dieaese[J].Trends Mol Med,2005;11(8):362-369.
[179]Van de Weyer PS,Muehlfeit M,Klose C,et al.A highly conserved tyrosine of Tim-3 is phosphorylated upon stimulation by its ligand galectin-9[J].Biochem Biophys Res Commun,2006:351(2):571-576.
[180]Gao PS,Mathias RA,Plunkett B,et al.Genetic variants of the T-cell immunoglobulin mucin 1 but not the T-cell immunoglobulin mucin 3 gene are associated with asthma in an African American population[J].J Allergy Clin Immunol,2005;115(5):982-988.
[181]Chae SC,Park YR,Lee YC,et al.The association of TIM-3 gene polymorphism with atopic disease in Korean population[J].Hum Immunol,2004;65(7):1427-1431.
[182]胡天丽,崔天盆,张才成,等.湖北地区汉族变应性哮喘患儿Tim-3启动子区基因多态性研究[J].中华检验医学杂志,2006;29(2):125-127.
[183]沈自尹.中西医结合防治支气管哮喘的探讨[J].中国中西医结合杂志,1995;15(7):426.
[184]彭素岚,白雪,罗家红,等.中西医结合治疗支气管哮喘缓解期患者免疫功能的变化[J].中国中西医结合急救杂志,1999;6(11):510.
[186]宋康,骆仙芳.支气管哮喘治疗的研究进展[J].浙江中医学院学报,2002;26(1):71.
[186]钟历勇,沈自尹,蔡定芳,等.补肾健脾活血三类复方时下丘脑-垂体-肾上腺-胸腺轴及CRF基因表达的影响[J].中国中西医结合杂志,1997;17(1):39.
© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号 地址：北京市海淀区学院路29号 邮编：100083 电话：办公室：(+86 10)66554848；文献借阅、咨询服务、科技查新：66554700 |